Latest insights

Catalyst - Episode 6: The impact of European data regulation on the life sciences and healthcare industry

Catalyst Episode 6

The GDPR, Data Act, AI Act, upcoming European Health Data Space (EHDS) Regulation and developments in competition law create an increasingly complex web for businesses to navigate.

Global | Webinar | February 13, 2024
Catalyst - Episode 5: Capturing the value of trade secrets

Catalyst Episode 5

In today’s ever-evolving business landscape, the importance of a comprehensive trade secrets strategy is skyrocketing.

Global | Webinar | December 04, 2023
Catalyst - Episode 4: M&A trends in Life Sciences Healthcare

Catalyst Episode 4

Members of NRF corporate team are joined by Steffen Brand, Senior Associate at Archimed private equity company, to discuss recent and anticipated trends in the sector.

Global | Webinar | February 09, 2023
Catalyst - Episode 3: Patent strategies

Catalyst Episode 3

The recent CNMC decision against MSD, Swiss/EU raids of Novartis, and Teva EC Statement of Objections suggest that European competition regulators are again considering the types of conduct by patent holders that can cross the line to become an abuse of dominance.

Global | Webinar | December 19, 2022
Catalyst - Episode 2: Excessive Pricing

Digital catalyst episode 2

Aspen came into spotlight when it acquired oncology drugs after their patents expired in 2009. Following the Italian Competition Authority's decision to fine Aspen, the European Commission stepped in to consider its conduct elsewhere in Europe, reaching a settlement intended to provide guidance concerning the application of excessive pricing in the pharmaceutical sector.

Global | Webinar | September 08, 2022
Catalyst - Episode 1: EHDS Regulation

Catalyst Episode 1

Ever increasing demand for, and reliance on, digital health solutions have led to the creation of large amounts of health data. On May 3, 2022, the EU Commission published its proposal for a European Health Data Space Regulation (EHDS Regulation) with the goal of enabling patients to control access to their health data while also enabling researchers, innovators and policy makers to use that health data to benefit society at large.

Global | Webinar | June 30, 2022


Contact

Miranda Cole
Miranda Cole
Partner
Email
miranda.cole@nortonrosefulbright.com
T: +32 (2) 2376198

Recent publications

IAR-Issue-22_Assests_Website-hero

Publication

International arbitration report

In this edition, we focused on the Shanghai International Economic and Trade Arbitration Commission’s (SHIAC) new arbitration rules, which take effect January 1, 2024.

Global | November 19, 2024

International arbitration

Publication

Road to COP29: Our insights

The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.

Global | November 11, 2024

Climate change and sustainability
Blue double-helix placed to the right with a digital blue backdrop

Publication

The GCR Guide to Life Sciences – Merger control: Procedural issues

Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.

Global | October 17, 2024

Life sciences and healthcare
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Register now